IVERIC bio, Inc. OPHT Income Statement

Iveric bio, inc. (OPHT)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Sep'12
Revenues
-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Collaboration revenue
-	-	-	-	-	-	-	-	-	-	-	-	36,850	-	50,369	52,149	25,548	51,505	86,298	0	0	-	0	-	-	-	-	-	-	-
Operating expenses:
Research and development
45,709	39,644	44,205	43,229	41,736	41,737	33,555	34,855	41,996	66,289	117,752	157,899	190,504	196,295	170,803	160,428	144,225	131,012	119,291	95,917	98,565	88,385	81,569	75,565	45,203	33,215	19,430	0	0	0
General and administrative
21,145	21,628	21,020	22,314	23,448	23,612	24,858	25,949	28,169	35,683	41,739	46,704	48,641	50,178	49,275	47,663	49,133	44,021	42,611	41,011	36,622	33,387	27,795	23,149	18,821	14,210	11,405	0	0	0
Total operating expenses
66,854	61,272	65,225	65,543	65,184	65,349	58,413	60,804	70,165	101,972	159,491	204,603	239,145	246,473	220,078	208,091	193,358	175,033	154,967	0	0	-	0	-	-	-	-	-	-	-
Total costs and expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	30,835	0	0	0
Loss from operations
-66,854	-61,272	-65,225	-65,543	-65,184	-65,349	-58,413	145,850	138,150	108,005	55,808	-194,290	-202,295	-195,564	-169,709	-155,942	-167,810	-123,528	-113,495	-52,394	-52,250	-80,513	-69,789	-98,714	-64,024	-47,425	-30,835	0	0	0
Interest income
1,839	2,151	2,459	2,601	2,586	2,389	2,121	1,875	1,617	1,522	1,516	1,534	1,636	1,704	1,688	1,599	1,292	971	0	0	0	-	-	116	-1,053	-1,454	0	0	0	-
Interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Loss on extinguishment of debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-
Other income
156	151	152	151	0	-16	-17	-28	-29	-34	88	80	-17	34	-81	-42	135	53	0	0	0	-	-	-	-	-	-	-	-	-
Interest income and other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-
Other loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,299	0	0	0
Loss before income tax provision (benefit)
-64,859	-58,970	62,386	62,209	62,402	62,024	-56,309	147,697	139,738	109,493	57,412	-192,676	-200,676	-193,826	-168,102	-154,385	-166,383	-122,504	-112,837	-52,002	-52,004	-80,296	-69,545	-99,408	-67,209	-51,145	-34,909	0	0	0
Income tax provision (benefit)
-3,405	-100	-397	-291	-1,295	-1,100	-5,690	-5,502	-4,503	-4,700	-52	-176	-435	-406	-5,316	-12,917	-17,729	-16,787	-6,450	31,866	0	-	0	0	-	-	-	-	-	-
Net Income (Loss) Attributable to Parent
-61,434	-58,859	62,733	62,425	63,659	63,087	-50,569	153,249	144,254	114,205	57,464	-192,500	-200,241	-193,420	-162,786	-141,468	-148,654	-105,717	0	0	0	-	-	-130,193	-67,209	-51,145	-34,909	0	0	0
Comprehensive loss
0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Add: accretion of preferred stock dividends
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5,891	7,667	0	0	0
Net loss attributable to common stockholders
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-57,036	-42,576	0	0	0
Earnings Per Share, Basic and Diluted [Abstract]
Net loss per common shares - basic and diluted (in dollars per share)
-0.28	-	-0.35	-0.35	-0.30	-	-0.41	-0.37	-0.36	-	-	-0.62	-1.20	-	-	-0.85	-1.03	-	-1.14	-1.08	-	-	-	-2.19	-	-	-	-8.07	-4.33	-4.07
Basic (in dollars per share)
-	-	-	-	-	-	-	-	-	-	5.26	-	-	-	-1.71	-	-	-	-	-	0.19	-	0.26	-	-0.64	-	-10.26	-	-	-
Dilutive (in dollars per share)
-	-	-	-	-	-	-	-	-	-	5.25	-	-	-	-1.71	-	-	-	-	-	0.19	-	0.25	-	-0.64	-	-10.26	-	-	-
Weighted average common shares outstanding:
Weighted average common shares outstanding - basic and dilutive (in shares)
53,426	-	41,552	41,477	41,427	-	36,202	36,188	36,153	-	-	35,858	35,804	-	-	35,392	35,256	-	34,782	34,353	-	-	-	33,373	-	-	-	1,470	1,470	1
Weighted Average Number of Shares Outstanding, Basic
-	-	-	-	-	-	-	-	-	-	35,971	-	-	-	35,594	-	-	-	-	-	34,154	-	33,531	-	32,282	-	1,795	-	-	-
Weighted Average Number of Shares Outstanding, Diluted
-	-	-	-	-	-	-	-	-	-	36,047	-	-	-	35,594	-	-	-	-	-	35,239	-	34,859	-	32,282	-	1,795	-	-	-